The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics.
WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version.
The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal.
WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%.
Rybakina, Vondroušová into Stuttgart quarters while Jabeur out
China's mega water diversion project benefits over 176 mln people
HKSAR chief executive signs safeguarding national security ordinance
French president calls again for ceasefire in Gaza
Closing arguments set in trial of an Arizona rancher charged in fatal shooting of unarmed migrant
China to build pilot zones for special needs education reform
Asian economy forecast to grow 4.5 pct in 2024: report
Israeli troops withdrawn from Gaza to prepare Rafah operation: defense minister
Jets might have a tough call to make between a playmaker or protection at No. 10 in the NFL draft
China making efforts to boost employment: Minister
Hilarious voice to text messages that'll make you wish people still used landlines
Hong Kong defends new security law